IDEXX Laboratories, Inc. · IDXX · Next earnings

IDEXX Laboratories, Inc. reports Monday, Feb 1, 2027

IDXX reports before market open with consensus EPS at $3.33 and revenue at $1.18B. Last quarter: IDEXX Raises FY2026 Outlook on Diagnostics and Software Growth

Reports Before market open88 days awayDate estimated Healthcare

What the street expects

Consensus for the coming report
Consensus EPS $3.33 Calendar consensus
Consensus revenue $1.18B Calendar consensus
Report date Feb 1, 2027 Monday, date estimated
Session Before market open 88 days away

Where IDXX left off: FY2026 Q3

Full report

IDEXX Raises FY2026 Outlook on Diagnostics and Software Growth

EPS surprise +6.2% Reported $3.96 vs $3.73
Revenue surprise +1.9% Reported $1.21B vs $1.19B
Stock move +21.8% Event window
Subsequent drift 0.0% Up to 20 sessions

Management raised FY2026 revenue guidance to $4.741–$4.767 billion and EPS guidance to $14.96–$15.16 per share, citing Q3 performance and ezyVet contribution.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • Foreign-exchange volatility could affect reported revenue and EPS.
  • Acquisition integration costs and dilution may weigh on margins.
  • Macroeconomic pressure could affect veterinary visit trends.
  • Pricing pressure remains a risk in diagnostics.

Questions analysts left open

  • Sensitivity of guidance to U.S. dollar strength.
  • Operating-margin effects of acquisitions and the recovery timeline.
  • Assumptions supporting InVue Dx placement targets.
  • Macroeconomic effects on veterinary visit trends.

Ask FN2 about IDXX next report

Transcript, numbers and history already loaded
What should I watch for in IDXX's next earnings report?How did IDXX guide last quarter, and is consensus above or below that?Give me the bull and bear case going into IDXX earnings.

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the IDXX recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent IDXX quarters

All IDXX earnings
+21.8%FY2026 Q3+3.6%FY2026 Q2-0.0%FY2026 Q1-4.6%FY2025 Q4

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q3

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.